Your browser doesn't support javascript.
loading
[Low-grade dural extranodal marginal zone lymphoma]. / Lymphome de la zone marginale localisé à la dure-mère.
Marguet, Florent; Fontanilles, Maxime; Bohers, Elodie; Derrey, Stéphane; Langlois, Olivier; Veresezan, Liana; Leprêtre, Stéphane; Sabourin, Jean-Christophe; Jardin, Fabrice; Laquerrière, Annie.
Afiliação
  • Marguet F; Inserm U1245, service d'anatomie pathologique, UNIROUEN, Normandie Université, CHU de Rouen, 76000 Rouen, France. Electronic address: florent.marguet@chu-rouen.fr.
  • Fontanilles M; Inserm U1245, IRON group, service d'oncologie médicale, Centre Henri-Becquerel, UNIROUEN, Normandie Université, 76000 Rouen, France.
  • Bohers E; Inserm U1245, Centre Henri-Becquerel, UNIROUEN, Normandie Université, 76000 Rouen, France.
  • Derrey S; Inserm U1239, service de neurochirurgie, UNIROUEN, Normandie Université, CHU de Rouen, 76000 Rouen, France.
  • Langlois O; Inserm U1239, service de neurochirurgie, UNIROUEN, Normandie Université, CHU de Rouen, 76000 Rouen, France.
  • Veresezan L; Service d'anatomie pathologique, Centre Henri-Becquerel, UNIROUEN, Normandie Université, 76000 Rouen, France.
  • Leprêtre S; Inserm U1245, service d'hématologie, Centre Henri-Becquerel, UNIROUEN, Normandie Université, 76000 Rouen, France.
  • Sabourin JC; Inserm U1245, service d'anatomie pathologique, UNIROUEN, Normandie Université, CHU de Rouen, 76000 Rouen, France.
  • Jardin F; Inserm U1245, service d'hématologie, Centre Henri-Becquerel, UNIROUEN, Normandie Université, 76000 Rouen, France.
  • Laquerrière A; Inserm U1245, service d'anatomie pathologique, UNIROUEN, Normandie Université, CHU de Rouen, 76000 Rouen, France.
Ann Pathol ; 40(3): 243-247, 2020 Jun.
Article em Fr | MEDLINE | ID: mdl-31948699
Primary low-grade dural marginal zone lymphoma is an indolent low grade lymphoma occurring especially among middle-aged immunocompetent women, and is not associated to an infectious process, contrary to gastric or intestinal marginal zone lymphomas. Dural location is rare since only 105 cases have been reported so far. We report herein on two additional cases, a 72-year-old woman and a 36-year-old man whose lymphoma was revealed by partial seizures and headaches. Morphological analysis of surgical specimens displayed a tumoral proliferation made of small lymphocytes arranged in sheets or in nodules with CD20, CD79a and BCL2-immunopositivity, but CD5 and CD10 negativity. Molecular analysis using a panel of 34 genes involved in lymphomagenesis disclosed a deletion of SOCS1 and TNFAIP3 genes, implicated in the JAK/STAT and NFκB pathways respectively in the first patient that could explain unfavourable prognosis despite complementary radiotherapy. No anomaly was identified in the second patient who is alive with no recurrence or progression seven years after the diagnosis. Currently, there are no standardized treatment schedules, but the vast majority of patients are treated by surgery, then radiotherapy followed by adjuvant chemotherapy using methotrexate alone or in combination with rituximab. Literature review indicates that five-year survival has been estimated at 96.7%, suggesting a better prognosis compared to other locations.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: Fr Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Linfoma de Zona Marginal Tipo Células B Tipo de estudo: Diagnostic_studies / Prognostic_studies Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: Fr Ano de publicação: 2020 Tipo de documento: Article